SINGAPORE
-�Media OutReach
- December 20, 2018 - MIMS, a leading multichannel provider of drug
information, medical communications and technology solutions in Asia Pacific,
is pleased to announce that it celebrated
three wins at the Media Publishers Association Awards in Singapore on 8th
November 2018.
Gracing
the awards night were (from left) MPF Business Director for Singapore Josephine
Cheong, Peggy Tio (3rd from left), MIMS CMO Sherlynn Tan, MIMS Doctor Regional Managing Editor
Elvira Manzano, and MPF Vice President for Hong Kong Karen Lo.
Overall
MIMS celebrated three wins. MIMS Doctor
celebrated two wins -- gold and bronze, respectively for the Front Cover of the
Year (Trade), for its July 2018 and February 2018 issues. MIMS Doctor designer Peggy Tio clinched the "Designer of the Year"
award.
The
awards ceremony was attended by over 35 publishing companies and 180 industry
stakeholders.� A panel of six judges
hand-picked the winners. Now on its 12th year, MPAS Awards
recognizes local publications and individuals for their remarkable contribution
in pushing for relevant content, interesting�campaigns and embracing innovation in the
media industry.
"This
has been a unique opportunity for MIMS, particularly for MIMS Doctor, to punch above its weight and lock our position as one
of the most trusted sources of healthcare information in Asia," said MIMS CEO
Yasunobu Sakai.� "We are thankful for the
awards and we draw strength from the recognition as we continuously reinvent
ourselves and work towards an engaging, cohesive, and progressive community of
doctors, patients, and healthcare partners."
�
About MIMS Group
Established in 1963, MIMS
is a multichannel provider of drug information, medical education and digital
solutions connecting healthcare communities. Our work empowers healthcare
communities to improve patient outcomes by facilitating knowledge exchange and
better decision-making. Today, MIMS is present in 13 countries (including
Taiwan) across Asia Pacific region with approximately two million healthcare
professional subscribers to its drug & resource portal, digital and print
publications.